SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-13-001764
Filing Date
2013-05-03
Accepted
2013-05-03 09:00:40
Documents
3
Period of Report
2013-06-14
Effectiveness Date
2013-05-03

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_050313.htm DEF 14A 439352
2 holliman.gif GRAPHIC 4782
3 logo.gif GRAPHIC 4500
  Complete submission text file 0001171843-13-001764.txt   453524
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33560 | Film No.: 13810451
SIC: 2834 Pharmaceutical Preparations